logo
menu

BorgWarner invests $10m in Enexor BioEnergy

news item image
BorgWarner has invested $10 million (€8.5 million) in Enexor BioEnergy, a company providing on-site renewable energy and carbon conversion solutions.

Enexor’s patented and modular Bio-CHP™ system uses locally sourced organics or plastic waste to generate clean on-site energy and can be deployed quickly in almost any setting. According to Enexor, each system can reduce up to 1,000 tonnes of CO2 equivalent emissions annually by reducing methane emissions released from landfills, offsetting fossil fuel-based power generation and reducing waste disposal transport emissions.

Joseph Fadool, vice president of BorgWarner and president and general manager of Emissions, Thermal, and Turbo Systems, said: “We have been impressed with the dedication and eco-friendly vision of the Enexor team and believe this investment is a natural extension of our comprehensive technology portfolio and actions we have already taken as part of our commitment to achieving carbon neutrality by 2035.

“We see immense opportunity for our collaboration with Enexor and are excited to see the impact its solutions, and our investment will have on the future of renewable power generation and the Earth’s carbon footprint.”

Enexor’s solutions align with and utilise BorgWarner’s existing eTurbine product line, which uses the remaining waste heat to generate electrical energy, as well as its industrial inverters through Cascadia Motion, wholly owned by BorgWarner. Together, the companies will explore future collaborations, including the potential for further CO2 reduction technologies and supplying battery packs.